Activation of IL-6R/JAK1/STAT3 signaling induces De Novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation
10.1158/1535-7163.MCT-12-0311
Saved in:
Main Authors: | Kim, S.M., Kwon, O.-J., Hong, Y.K., Kim, J.H., Solca, F., Ha, S.-J., Soo, R.A., Christensen, J.G., Lee, J.H., Cho, B.C. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/116210 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance
by: Shimamura, T, et al.
Published: (2020) -
HOMOLOGY MODELING OF EGFR MUTATED L858R/T790M/C797S
by: Alif Aditya, Faris -
Anti-myeloma effects of icariin are mediated through the attenuation of JAK/STAT3-dependent signaling cascade
by: Jung Y.Y., et al.
Published: (2019) -
Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities
by: Chua, Khi Pin, et al.
Published: (2024) -
The de novo selection of drug-resistant malaria parasites
by: N. J. White, et al.
Published: (2018)